We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$29.2B
AUM Growth
+$1.4B
Cap. Flow
+$144M
Cap. Flow %
0.49%
Top 10 Hldgs %
23.08%
Holding
3,780
New
179
Increased
1,287
Reduced
1,288
Closed
176

Sector Composition

Rank Sector Weight
1 Industrials 12.17%
2 Financials 11.31%
3 Healthcare 10.5%
4 Technology 9.1%
5 Consumer Staples 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUTR
3426
DELISTED
Nutraceutical International Co
NUTR
$2K ﹤0.01%
+75
New +$2.54K
CEB
3427
DELISTED
CEB Inc.
CEB
$2K ﹤0.01%
26
-8
-24% -$615
VIA
3428
DELISTED
Viacom Inc. Class A
VIA
$2K ﹤0.01%
40
REGI
3429
DELISTED
Renewable Energy Group, Inc.
REGI
$2K ﹤0.01%
238
TRCO
3430
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$2K ﹤0.01%
56
-6,060
-99% -$205K
AST
3431
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$2K ﹤0.01%
687
FGL
3432
DELISTED
Fidelity & Guaranty Life
FGL
$2K ﹤0.01%
70
ABUS icon
3433
Arbutus Biopharma
ABUS
$883M
$1K ﹤0.01%
200
AHRT
3434
AH Realty Trust
AHRT
$526M
$1K ﹤0.01%
66
-411
-86% -$5.72K
ASG
3435
Liberty All-Star Growth Fund
ASG
$323M
$1K ﹤0.01%
+187
New +$828
AXTI icon
3436
AXT Inc
AXTI
$3.46B
$1K ﹤0.01%
100
BCLI
3437
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1K ﹤0.01%
18
CFA icon
3438
VictoryShares US 500 Volatility Wtd ETF
CFA
$533M
$1K ﹤0.01%
30
-142
-83% -$5.96K
CLDX icon
3439
Celldex Therapeutics
CLDX
$2.78B
$1K ﹤0.01%
+25
New +$1.3K
CMCM
3440
Cheetah Mobile
CMCM
$89.4M
$1K ﹤0.01%
14
CRSP icon
3441
CRISPR Therapeutics
CRSP
$4.68B
$1K ﹤0.01%
+39
New +$766
CYTK icon
3442
Cytokinetics
CYTK
$11.1B
$1K ﹤0.01%
+74
New +$865
DALN
3443
DELISTED
DallasNews
DALN
$1K ﹤0.01%
40
DOG
3444
ProShares Short Dow30
DOG
$97.2M
$1K ﹤0.01%
16
-575
-97% -$42.3K
DRD
3445
DRDGold
DRD
$1.77B
$1K ﹤0.01%
200
ECON icon
3446
Columbia Emerging Markets Consumer ETF
ECON
$331M
$1K ﹤0.01%
+31
New +$741
FAN icon
3447
First Trust Global Wind Energy ETF
FAN
$283M
$1K ﹤0.01%
42
FCNCA icon
3448
First Citizens BancShares
FCNCA
$25.2B
$1K ﹤0.01%
4
KYNB
3449
Kyntra Bio
KYNB
$28.6M
$1K ﹤0.01%
1
FLWS icon
3450
1-800-Flowers.com
FLWS
$249M
$1K ﹤0.01%
117

Similar funds

US Bancorp's Q1 2017 Portfolio in Review

As of Q1 2017, US Bancorp held 3,780 positions worth $29.2B, up 5% from $27.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q1 2017 filing shows 179 new, 1,287 increased, 1,288 reduced and 176 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M. The largest sale was Berkshire Hathaway Class A, an estimated $44.4M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 37,511 shares worth $2.04M.
  • US Bancorp added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $43M increase.
  • US Bancorp's biggest Q1 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $44.4M.
  • US Bancorp fully exited St Jude Medical in Q1 2017, selling an estimated $23.2M.
  • US Bancorp's ten largest holdings make up 23% of its $29.2B portfolio in Q1 2017.
  • US Bancorp opened 179 new positions and closed 176 in Q1 2017.
  • US Bancorp's portfolio value rose 5% quarter-over-quarter to $29.2B.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.